口服与外用他克莫司联合治疗抗治疗性坏疽性脓皮病 - Suppr

Suppr

超能文献

Combination oral and topical tacrolimus in therapy-resistant pyoderma gangrenosum.

作者信息

Jolles S, Niclasse S, Benson E

出版信息

Br J Dermatol. 1999 Mar;140(3):564-5. doi: 10.1046/j.1365-2133.1999.02746.x.

DOI:10.1046/j.1365-2133.1999.02746.x

PMID:10233301

Abstract

摘要

相似文献

Combination oral and topical tacrolimus in therapy-resistant pyoderma gangrenosum.

Br J Dermatol. 1999 Mar;140(3):564-5. doi: 10.1046/j.1365-2133.1999.02746.x.

Pyoderma gangrenosum successfully treated with topical tacrolimus.

G Ital Dermatol Venereol. 2019 Jun;154(3):361-363. doi: 10.23736/S0392-0488.18.05735-8. Epub 2018 Jan 24.

Successful treatment of periostomal pyoderma gangrenosum using topical tacrolimus.

Br J Dermatol. 2004 Feb;150(2):387-8. doi: 10.1111/j.1365-2133.2003.05804.x.

Topical tacrolimus for pyoderma gangrenosum.

Lancet. 1998 Mar 14;351(9105):832. doi: 10.1016/S0140-6736(05)78962-5.

Successful treatment of pyoderma gangrenosum associated with juvenile idiopathic arthritis with a combination of topical tacrolimus and oral prednisolone.

Clin Rheumatol. 2009 Apr;28(4):489-90. doi: 10.1007/s10067-008-1066-y. Epub 2009 Feb 3.

Successful topical tacrolimus (FK506) therapy in a child with pyoderma gangrenosum.

J Pediatr Gastroenterol Nutr. 2002 May;34(5):555-7. doi: 10.1097/00005176-200205000-00015.

Successful tacrolimus (FK506) therapy in a child with pyoderma gangrenosum.

Arch Dis Child. 2005 May;90(5):531. doi: 10.1136/adc.2004.063370.

Penile pyoderma gangrenosum treated with topical tacrolimus.

Arch Dermatol. 2005 Sep;141(9):1175-6. doi: 10.1001/archderm.141.9.1175.

Topical tacrolimus (FK 506) is effective in the treatment of pyoderma gangrenosum.

J Am Acad Dermatol. 2000 Feb;42(2 Pt 1):304-5. doi: 10.1016/s0190-9622(00)90149-x.

Topical tacrolimus for pyoderma gangrenosum: Another report.

J Dermatol. 2006 Mar;33(3):232. doi: 10.1111/j.1346-8138.2006.00055.x.

引用本文的文献

Cutaneous Manifestations of Inflammatory Bowel Disease: A Basic Overview.

Am J Clin Dermatol. 2022 Jul;23(4):481-497. doi: 10.1007/s40257-022-00689-w. Epub 2022 Apr 20.

Pyoderma gangrenosum: From historical perspectives to emerging investigations.

Int Wound J. 2020 Oct;17(5):1255-1265. doi: 10.1111/iwj.13389. Epub 2020 May 6.

Current clinical issue of skin lesions in patients with inflammatory bowel disease.

Clin J Gastroenterol. 2019 Dec;12(6):501-510. doi: 10.1007/s12328-019-00958-y. Epub 2019 Mar 5.

Skin Manifestations of Inflammatory Bowel Disease.

Clin Rev Allergy Immunol. 2017 Dec;53(3):413-427. doi: 10.1007/s12016-017-8617-4.

European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.

Gut. 2006 Mar;55 Suppl 1(Suppl 1):i36-58. doi: 10.1136/gut.2005.081950c.

Treatment of Extraintestinal Manifestations in Inflammatory Bowel Disease.

Curr Treat Options Gastroenterol. 2003 Jun;6(3):201-212. doi: 10.1007/s11938-003-0002-0.

Extraintestinal Complications of Inflammatory Bowel Disease.

Curr Treat Options Gastroenterol. 2001 Jun;4(3):227-243. doi: 10.1007/s11938-001-0035-1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Combination oral and topical tacrolimus in therapy-resistant pyoderma gangrenosum.

Br J Dermatol. 1999 Mar;140(3):564-5. doi: 10.1046/j.1365-2133.1999.02746.x.

Pyoderma gangrenosum successfully treated with topical tacrolimus.

G Ital Dermatol Venereol. 2019 Jun;154(3):361-363. doi: 10.23736/S0392-0488.18.05735-8. Epub 2018 Jan 24.

Successful treatment of periostomal pyoderma gangrenosum using topical tacrolimus.

Br J Dermatol. 2004 Feb;150(2):387-8. doi: 10.1111/j.1365-2133.2003.05804.x.

Topical tacrolimus for pyoderma gangrenosum.

Lancet. 1998 Mar 14;351(9105):832. doi: 10.1016/S0140-6736(05)78962-5.

Successful treatment of pyoderma gangrenosum associated with juvenile idiopathic arthritis with a combination of topical tacrolimus and oral prednisolone.

Clin Rheumatol. 2009 Apr;28(4):489-90. doi: 10.1007/s10067-008-1066-y. Epub 2009 Feb 3.

Successful topical tacrolimus (FK506) therapy in a child with pyoderma gangrenosum.

J Pediatr Gastroenterol Nutr. 2002 May;34(5):555-7. doi: 10.1097/00005176-200205000-00015.

Successful tacrolimus (FK506) therapy in a child with pyoderma gangrenosum.

Arch Dis Child. 2005 May;90(5):531. doi: 10.1136/adc.2004.063370.

Penile pyoderma gangrenosum treated with topical tacrolimus.

Arch Dermatol. 2005 Sep;141(9):1175-6. doi: 10.1001/archderm.141.9.1175.

Topical tacrolimus (FK 506) is effective in the treatment of pyoderma gangrenosum.

J Am Acad Dermatol. 2000 Feb;42(2 Pt 1):304-5. doi: 10.1016/s0190-9622(00)90149-x.

Topical tacrolimus for pyoderma gangrenosum: Another report.

J Dermatol. 2006 Mar;33(3):232. doi: 10.1111/j.1346-8138.2006.00055.x.

引用本文的文献

Cutaneous Manifestations of Inflammatory Bowel Disease: A Basic Overview.

Am J Clin Dermatol. 2022 Jul;23(4):481-497. doi: 10.1007/s40257-022-00689-w. Epub 2022 Apr 20.

Pyoderma gangrenosum: From historical perspectives to emerging investigations.

Int Wound J. 2020 Oct;17(5):1255-1265. doi: 10.1111/iwj.13389. Epub 2020 May 6.

Current clinical issue of skin lesions in patients with inflammatory bowel disease.

Clin J Gastroenterol. 2019 Dec;12(6):501-510. doi: 10.1007/s12328-019-00958-y. Epub 2019 Mar 5.

Skin Manifestations of Inflammatory Bowel Disease.

Clin Rev Allergy Immunol. 2017 Dec;53(3):413-427. doi: 10.1007/s12016-017-8617-4.

European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.

Gut. 2006 Mar;55 Suppl 1(Suppl 1):i36-58. doi: 10.1136/gut.2005.081950c.

Treatment of Extraintestinal Manifestations in Inflammatory Bowel Disease.

Curr Treat Options Gastroenterol. 2003 Jun;6(3):201-212. doi: 10.1007/s11938-003-0002-0.

Extraintestinal Complications of Inflammatory Bowel Disease.

Curr Treat Options Gastroenterol. 2001 Jun;4(3):227-243. doi: 10.1007/s11938-001-0035-1.